SCM
AURA icon

Sterling Capital Management’s Aura Biosciences AURA Stock Holding History

Sterling Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.5K Sell
1,121
-685
-38% -$3.93K ﹤0.01% 2527
2025
Q4 		$9.84K Sell
1,806
-279
-13% -$1.66K ﹤0.01% 2610
2025
Q3 		$12.9K Buy
2,085
+1,371
+192% +$8.97K ﹤0.01% 2355
2025
Q2 		$4.47K Sell
714
-86
-11% -$503 ﹤0.01% 2572
2025
Q1 		$4.69K Sell
800
-686
-46% -$5.19K ﹤0.01% 2194
2024
Q4 		$12.2K Buy
1,486
+1,323
+812% +$12.5K ﹤0.01% 2075
2024
Q3 		$1.45K Buy
+163
New +$1.4K ﹤0.01% 2353

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sterling Capital Management's AURA Position: Q1 2026 in Review

Sterling Capital Management reduced its Aura Biosciences (AURA) stake by 38% in Q1 2026, selling an estimated $3.93K and leaving 1,121 shares worth $7.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2527.

Sterling Capital Management first reported a position in AURA in Q3 2024 and has held it in 7 quarters since. The position peaked at $12.9K in Q3 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Sterling Capital Management held 1,121 shares of Aura Biosciences worth $7.5K as of Q1 2026.
  • Sterling Capital Management sold 685 Aura Biosciences shares in Q1 2026, an estimated $3.93K.
  • Aura Biosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2527 holding.
  • Sterling Capital Management first reported a position in Aura Biosciences in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's Aura Biosciences position peaked at $12.9K in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.